SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-066855
Filing Date
2021-05-14
Accepted
2021-05-14 16:08:41
Documents
60
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2111695d1_10q.htm 10-Q 379520
2 EXHIBIT 31.1 tm2111695d1_ex31-1.htm EX-31.1 9808
3 EXHIBIT 31.2 tm2111695d1_ex31-2.htm EX-31.2 9681
4 EXHIBIT 32.1 tm2111695d1_ex32-1.htm EX-32.1 3676
5 EXHIBIT 32.2 tm2111695d1_ex32-2.htm EX-32.2 3691
  Complete submission text file 0001104659-21-066855.txt   4122831

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eyen-20210331.xml EX-101.INS 1070141
7 XBRL TAXONOMY EXTENSION SCHEMA eyen-20210331.xsd EX-101.SCH 44738
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eyen-20210331_cal.xml EX-101.CAL 38958
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eyen-20210331_def.xml EX-101.DEF 117398
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyen-20210331_lab.xml EX-101.LAB 302130
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyen-20210331_pre.xml EX-101.PRE 254929
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38365 | Film No.: 21924621
SIC: 2834 Pharmaceutical Preparations